RetinaLyze Unveils Advanced Glaucoma Progression AI with Glaucoma Index of Progression (GIP)

In alignment with World Sight Day 2024's theme “Children, Love Your Eyes,” RetinaLyze has announced the launch of its Advanced Glaucoma Progression AI.

Getting Started with Eye Screening as an Optometrist: Here’s how you do it!

If you're considering adding eye screening services to your practice, there are several important factors to keep in mind.

Consultations for ESBs and a new PDF report

This update focuses on streamlining workflows for optometrists and enhancing the accessibility of data for both users and external specialists.

Summer holidays are over, what's happened with RetinaLyze?

As we step into the latter part of the year, it’s the perfect time to reflect on the exciting developments that have unfolded at RetinaLyze in 2024. Our commitment to enhancing eye care through cutting-edge technology has led to several significant advancements that we’re thrilled to share.

RetinaLyze featured in The College of Optometrists Acuity Spring 2024

We are incredibly grateful for the opportunity to contribute to this significant discussion on the future of health diagnostics through oculomics, as featured in a recent publication called “Is early diagnosis always better” by The College of Optometrists.

RetinaLyze launches a new software version to enhance the workflow of the eye specialist

RetinaLyze has launched a new version of their fundus analysis software offering a range of improvements designed to streamline workflows and assist in decision-making.

RetinaLyze AI shows an AUC of 93,4% in new Ph.D. thesis

New Ph.D. thesis explores the use of artificial intelligence in screening for diabetic retinal changes in diabetes patients.

Meet RetinaLyze at OPTI 2023

Artificial intelligence and eye screening: A topic that has been discussed in recent weeks not only in webinars, but generally in the industry. Those who have not yet had the chance to experience an AI-based eye screening live can do so at any time at OPTI 2023. The algorithms of RetinaLyze allow eye screening using artificial intelligence with fundus cameras or OCT devices.

RetinaLyze System receives ISO 13485:2016 certification

RetinaLyze System's quality management system has been independently audited to be compliant with ISO 13485:2016.

Launching RetinaLyze OCT – detect over 70 pathological signs in 45 seconds

We are excited to introduce our groundbreaking new service, RetinaLyze OCT, that supports optometrists in detecting more than 70 pathological signs of retinal conditions.

Abnormal GDF with few areas of low hemoglobin concentration

Guest post by Prof. Manuel Gonzalez de la Rosa: How can a very abnormal GDF, be compatible with the presence of only a few areas of low hemoglobin concentration?

Paper accepted in Br J Ophthal. demonstrating that RetinaLyze Glaucoma has a similar diagnostic capability to Angio-OCT

A paper has been accepted in the prestigious British Journal of Ophthalmology, demonstrating that Laguna ONhE/RetinaLyze Glaucoma has a diagnostic capability similar to a modern and expensive Angio-OCT.

opti2020 - RetinaLyze is proud of the successful start to 2020

The entire RetinaLyze team and their partners were close to our customers this year. At a total of six exhibition stands, visitors were able to learn more about eye screening using artificial intelligence.

Meet RetinaLyze at OPTI 2020

Meet us at OPTI 2020 and try the artificial intelligence enabled eye-screening software, RetinaLyze. Find us in Hall C6 Booth 426 from the 10th to the 12th of January 2020

RetinaLyze v3.7.1

We are proud to present RetinaLyze version 3.7.1, which consists of upgrades to the Glaucoma algorithm.

Prof. Gonzalez de la Rosa presents new groundbreaking performance of the Laguna ONhE/RetinaLyze Glaucoma algorithm

Professor Gonzalez de la Rosa (GR), prime inventor of the Laguna ONhE/RetinaLyze Glaucoma algorithm, was invited to lecture at two recent meetings in Madrid.

2018 - Year in review and our fifth birthday!

2018 was quite a year for RetinaLyze System A/S (Ltd.). We launched the glaucoma-algorithm, gave RetinaLyze a visual overhaul and reached 1 million screenings for Diabetic Retinopathy, AMD and Glaucoma!

RetinaLyze receives funding to detect diseases such as Alzheimer's using AI

RetinaLyze teams up with two universities to develop the next generation of eye screening algorithms, which may detect new diseases in retinal images, such as Alzheimer's.

AI as an efficient co-pilot in the detection of diseases causing preventable blindness

The Rotary Medical Mission (RMM) is in Malawi to provide free eye services including provision of eye and sun glasses, and check ups. Our Head of Global Sales, Lasse Bundgaard, joined them in Lilongwe, Malawi at the Kamuzu Central Hospital.

RetinaLyze v3.2.0

We are proud to present RetinaLyze version 3.2.0, which consists of major upgrades to the Glaucoma algorithm and smaller changes to make the system easier to use.

Partnership announced at IX Biennial Congress of Glaucoma 2018

We're proud to announce our partnership with Unica Pharma, who launched the RetinaLyze Glaucoma software in Argentina this weekend. The software was presented by Dr. Jens Thygesen at the IX Biennial Congress of Glaucoma organized by ASAG.

Why it's important to have your eyes screened for glaucoma

In this article, we're going to be specifically looking at the importance of regular eye checks and what happens if you neglect to visit your local GP, or ophthalmic specialist.

RetinaLyze’ new AI algorithm detects signs of glaucoma using retinal images

A team of researchers have developed an algorithm, which automatically detects abnormalities and changes linked to the eye disease glaucoma. The new algorithm is now offered as a part of the software, RetinaLyze, which provides instant eye screening results for the 3 most frequent diseases causing blindness glaucoma, macular degeneration and diabetic retinopathy.

RetinaLyze Glaucoma - A revolution in glaucoma screening

We are excited to present a fantastic new service in the RetinaLyze portfolio. RetinaLyze Glaucoma can screen for glaucoma using only fundus images, but achieves similar performance to OCT's and visual perimetry.

Glaucoma is now the second leading cause of blindness

Glaucoma is becoming an increasingly important cause of blindness, as the world’s population ages. New statistics gathered by WHO in 2002, show that glaucoma is now the second leading cause of blindness globally, after cataracts.

OPTI 2018

Danke! Thank you! Grazie! Merci! Gracias! Teşekkür ederiz! Bedankt! Спасибо! 谢谢! The RetinaLyze team thanks all visitors for a great fair in Munich and look forward to opti 2019!

Looking back at RetinaLyze's 2017

Wow, 2017 was quite a year for RetinaLyze System A/S. We've screened over 150.000 people for Diabetic Retinopathy and AMD, won an award and launched both massive features and a host of enhancements.

Meet RetinaLyze at OPTI 2018

Meet us at OPTI 2018 and try the artificial intelligence enabled eye-screening software, RetinaLyze. Find us in Hall C4 Stand 525 from the 12th to the 14th of January 2018

RetinaLyze wins award

Aarhus Municipality and CareWare-Next awarded the CareWare-Next prizes, the nationwide competition for welfare technology, on Tuesday November 14th.

RetinaLyze nominated for an award

Eight welfare technologies and aids were nominated in the CareWare-Next competition on Wednesday 11 October.

RetinaLyze v2.1.6

We are proud to present RetinaLyze version 2.1.6, which consists of small improvements to make the system easier to use.

COECSA 2017 in Uganda

We are excited to be entering Uganda with our automated eye screening solution for the first time. We had our first ever attendance of the COECSA meeting in Kampala, Uganda this year.

Using RetinaLyze in outreach clinics

We saw 49 patients at our outreach diabetic retinal screening clinic in Kampala, Uganda referring 16 for a range of eye conditions.

RetinaLyze API goes live

We are excited to present a fantastic new product in the RetinaLyze portfolio. We have been working on it for quite some time, and are looking forward to the new possibilities the product creates.

Terry Cooper joining RetinaLyze

We’re excited to announce that Terry Cooper (former Regional Manager at VOLK optical) will soon be joining us in the important UK market.

Training session in Kenya

Here is a series of images taken during a training session Terry Cooper and Paul Machengo attended at Coast Provincial General Hospital in Mombasa, Kenya.

RetinaLyze v2.1.0

We are proud to present RetinaLyze version 2.1.0, which consists of small improvements to make the system easier to use.

RetinaLyze v2.0.1

We are proud to present RetinaLyze version 2.0.1, which consists of an added photo quality assessment, speed optimizations, and even better security.

RetinaLyze v1.3.4

We are proud to present RetinaLyze version 1.3.4, which consists of a series of updates for the Eye-Specialist Backup and a new printable PDF for all customers as standard.

Romantic Hole Syndrome of the Retina

On this day, Valentine’s Day, romance and hearts are all around us – even in our eyes – literally. These photos are a submission of a 59-year-old female from Greece, who has Stargardt’s disease.

World Diabetes Day 2016

World Diabetes Day, November 14, is an annual reoccurring day, where diabetes is in focus. This year’s theme “Eyes on Diabetes” is a theme well aligned with our mission in RetinaLyze: Preventing blindness.

Diabetes is the leading cause of blindness

Many diabetes complications can be picked up in their early stages by screening programmes that allow treatment to prevent them from becoming more serious.

Disruptive Innovation Theory

Disruptive innovation theory – what is it actually all about? Disruption has indeed become a buzzword! In such an extent that even our law company is hosting an event with the headline “Digitalization and disruption – from buzzword to business”.

Diabetes Awareness Month – Eyes on Diabetes

The theme of World Diabetes Day 2016 is Eyes on Diabetes, with particular focus on promoting the importance of screening to ensure early diagnosis of type 2 diabetes and treatment to reduce the risk of serious complications.

AAO 2016 in Chicago

Health care is changing at a rapid level, and it is amazing what people are doing in research and in advancing the field – trying to make care for patients better. The American Academy of Ophthalmology (AAO) hosted their annual meeting with the overall theme of this year: Innovate

Eye screening in Kenya

In cooperation with Novo Nordisk, our Kenyan team set out to create awareness about eye screening and diabetes complication in hospitals and rural areas.

Hall of Frames 2016

The Hall of Frames – “The exhibition for beautiful glasses” (as the official tagline states) – takes departure in the glasses industry and sets the stage for introducing and discussing several themes of relevance for optometrists operating in this market.

Optik Austria 2016

ESCRS 2016

We met clinicians who were amazed by the opportunity to let their nurses or even non-medical personal perform retinal image capturing and pre-screening using the RetinaLyze software, letting them focus on diagnosing and treat patients who are not healthy.

RetinaLyze v1.3.1

We are proud to present RetinaLyze version 1.3.1, which consists of a new search feature, support for timezones and a lot of backend re-structuring to allow for a more scalable and flexible system.

RetinaLyze v1.3.0

We are proud to present RetinaLyze version 1.3.0, which consists of some major design changes, changes in the AMD-analysis’ results, the addition of new features and a lot of new languages.

Partnering to combat blindness

This past November, Retinalyze Spain and the Eyes of the World Foundation signed a three-year partnership.

ESCRS 2015 in Barcelona

European Society Of Cataract & Retractive Surgeons 2015 is coming to an end. We’d like to take thank all visitors and business partners for the overwhelming interest in the RetinaLyze screening software.

Know the danger signs of future blindness

You can make it a weekly habit to cover one eye with your hand and check whether there is a difference in the number of persons and item as well as any difference in the subtitles when watching TV.

Worlds first bionic eye

The doctors in the british city of Manchester have successfully made the world’s first bionic eye implant.

Interested in preventing blindness?

Since we are experiencing an increase in demand caused by an increased focus on retinal screening to detect diabetes related eye diseases, we are looking for distributors worldwide.

RetinaLyze v1.2.4

We are proud to present RetinaLyze version 1.2.4. This version brings a number of updates that make the daily use of RetinaLyze easier and faster.

RetinaLyze v1.2.3

RetinaLyze version 1.2.3 is a smaller update that consists of a few additions.

Implementation in Profil Optik Denmark

We have just completed the first training workshops over two wonderful days with around 120 highly competent opticians/optometrists from Profil Optik.

RetinaLyze v1.2.2

We are proud to present RetinaLyze version 1.2.2, which consists of a few minor design changes and a better experience in older browsers (specifically Internet Explorer 8 and younger), together with a new Help Center with guides and news.

RetinaLyze v1.2.1

We are proud to present RetinaLyze version 1.2.1 that brings the possibility to zoom in on and download photographs (with and without indications). In addition, the working area is translated into Danish and there are large improvements in terms of safety.

Launch of optometry giving sight in Mexico

Diabetes is becoming an epidemic